Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd.
About Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd.
Categories
-
CN
-
2019On CPHI since
Products from Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd. (3)
-
Product Dexlansoprazole Sodium
produced under GMP conditions, indicated for Gastric ulcer, duodenal ulcer and reflux esophagitis -
Product Calcifediol
in compliance with the monographs of USP/EP/BP, produced under GMP conditions, indicated for Osteoporosis, Rickets and Osteomalacia. -
Product Maxacalcitol
produced under GMP conditions, indicated for Secondary hyperparathyroidism and Psoriasis
Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd. Resources (2)
-
News Heron Pharma attended CPHI China 2019
Many thanks to the customers visiting us on at booth E2G39 on CPHI China 2019. Let's meet again on CPHI China 2020 at W2B25 in Shanghai, Jun. 22-24th 2020. -
Video Heron Pharma Interview
Heron Pharmaceutical Science & Technology Co., Ltd. was founded in 2013 and grew fast in the past 6 years. Chuangye Jiangsu 8090+ interviewed Heron Pharma on July 4th, 2019 since this company is one successful case of New Born Company in Nanjing City. This video could help more people to understand Heron Pharma and know more interest details how we work.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance